“We are looking forward to exhibiting at PTCOG this year and showcasing all the great products .decimal’s staff is working on to improve the quality of patient-specific devices for proton therapy.” said Richard Sweat, President and CEO of .decimal, Inc.
Sanford, Florida (PRWEB) April 29, 2011
.decimal, Inc. (pronounced dot decimal), an innovative manufacturer of patient-specific medical devices for radiation therapy, plans to showcase an array of cutting-edge medical devices for radiation therapy at the Particle Therapy Co-Operative Group (PTCOG) annual meeting in Philadelphia, PA, on May 12-14, 2011.
As a leader in radiation therapy device manufacturing, .decimal® plans to highlight future product enhancements for proton therapy including: beam divergent apertures, smooth range compensators, and alternative material range compensators.
PTCOG coordinates a leading medical conference on particle acceleration treatment for cancerous tumors, a hot topic for radiation oncology professionals. The event also attracts clinicians interested in providing patients with precise dosage using the latest radiation technology devices.
“We are looking forward to exhibiting at PTCOG this year and showcasing all the great products .decimal’s staff is working on to improve the quality of patient-specific devices for proton therapy.” said Richard Sweat, President and CEO of .decimal, Inc. “Our company has a proven track record for delivering the right device, for the right patient, and to the right location—at the right time.”
Given its diverse membership, PTCOG provides .decimal® with an effective launch pad for communicating value and new products to radiation therapy and healthcare professionals worldwide. The event helps broaden patients’ cancer treatment options.
Based in Central Florida—a region known for its high-quality healthcare industry— .decimal, Inc. manufactures patient-specific medical devices using more than 30 Mazak precision-milling machines. The company’s track record of manufacturing more than 150,000 FDA-compliant medical devices involves hundreds of cancer treatment centers across the U.S and Japan.
This year PTCOG 50 will be held at the Marriott Philadelphia Downtown in Philadelphia, PA from May 12-14, 2011 and .decimal® will be exhibiting its patient-specific medical devices for radiation therapy at booth 8.
For more information about .decimal® patient-specific medical devices for proton therapy, visit http://www.dotdecimal.com/protons.
About .decimal, Inc.
.decimal® is a medical device manufacturer of patient-specific radiation therapy devices including BolusECT® compensators for electron conformal therapy, missing tissue compensators, modulators for advanced Solid IMRT® delivery, and apertures and range compensators used in proton therapy. .decimal® has been serving radiation oncology professionals and their patients for 25 years in the U.S. and is currently expanding its markets to cancer patients on a global scale.
For more information on .decimal® and its products, please visit http://www.dotdecimal.com.
About the Particle Therapy Co-Operative Group (PTCOG 50) Annual Meeting
The Annual PTCOG 50 meeting in Philadelphia, PA will be held May 8-14, 2011 at the Marriott Philadelphia Downtown with the purpose of educating attendees on the clinical, physical and biological basics of ion therapy and to acquaint them with new advancements and developments in particle therapy. The meeting is designed for medical physicists, health physicists, radiation oncologists, oncologists in other disciplines, engineers, medical dosimetrists, dosimetrists, radiation therapists, administrators, and others interested in particle therapy.
For more information on PTCOG 50, please visit http://www.ptcog50.com/